Kaori Watanabe

发表

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Taichi Hayashi, T. Sumida, N. Miyasaka, 2015, Arthritis Research & Therapy.

A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan

S. Bae, N. Miyasaka, J. Jun, 2014, Modern rheumatology.

Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia

Y. Takasaki, N. Miyasaka, Kazuyoshi Saito, 2015, Modern rheumatology.

Infected abdominal aortic aneurysm caused by nontyphoid Salmonella in an immunocompromised patient with rheumatoid arthritis

N. Miyasaka, Y. Nonomura, R. Koike, 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis

A. Sato, N. Miyasaka, T. Nanki, 2010, Modern rheumatology.

Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis

K. Matsushima, N. Miyasaka, T. Imai, 2011, Arthritis research & therapy.

Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study

Y. Takasaki, H. Hagiyama, N. Miyasaka, 2015, The Journal of Rheumatology.

Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients

S. Sawada, A. Ogata, N. Miyasaka, 2012, Modern rheumatology.

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

T. Sumida, N. Miyasaka, Yoshiya Tanaka, 2014, Rheumatology International.

Colitis associated with Clostridium difficile in specific-pathogen-free C3H-scid mice.

Kaori Watanabe, M. Ikeda, S. Matsushita, 2007, The Journal of veterinary medical science.

A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus.

N. Miyasaka, A. Takamura, T. Nanki, 2009, Rheumatology.

Pathogenic role of CXCR7 in rheumatoid arthritis.

T. Schall, N. Miyasaka, A. Matsuda, 2010, Arthritis and rheumatism.

Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg–Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG

N. Miyasaka, Michinobu Tanaka, T. Nanki, 2012, Modern rheumatology.

Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules

S. Ito, T. Sumida, N. Miyasaka, 2012, Annals of the rheumatic diseases.

A case of lupus cystitis with a history of idiopathic thrombocytopenic purpura

H. Yoshimatsu, M. Haranaka, H. Tatsukawa, 2004, Modern rheumatology.

[A case of relapsed acute myeloid leukemia with brain white matter lesions].

Yoshiaki Abe, Kaori Watanabe, O. Imataki, 2007, Gan to kagaku ryoho. Cancer & chemotherapy.

[A case of progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus].

N. Miyasaka, T. Nanki, Kaori Watanabe, 2008, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.